Sr Director, Medical Education and Programs at Gilead Sciences

Parsippany, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, HealthcareIndustries

Requirements

Visionary leadership to guide and implement medical education and programs strategy aligned with organizational goals and stakeholder needs
Ability to provide strategic direction and leadership for the medical education and programs team, fostering innovation and outcomes
Collaboration with cross-functional teams (e.g., Legal, Compliance, Public Affairs, and Medical Affairs) to develop and implement integrated strategies aligned with Medical Affairs goals
Ensure compliance with ACCME, FDA, OIG, and other relevant guidelines, as well as Gilead policies and federal/state/local statutes and regulations
Stay abreast of industry trends and regulatory changes in medical education to inform decision-making and strategic planning
Cultivate and maintain relationships with key stakeholders, including medical professionals, professional associations, and educators
Operational oversight, including effective management of budgeting, resource allocation, and performance management
Ability to navigate complex challenges and drive strategic objectives in a rapidly evolving healthcare landscape
Experience as a people leader to evolve culture and create an inclusive, developmental environment (as per general Gilead expectations)

Responsibilities

Determine strategy for medical education and programs based on organizational goals, outcomes data, and stakeholder needs
Conduct medical education needs assessments to select industry-leading medical education programs designed to optimize patient outcomes
Develop and maintain relationships with key stakeholders, including medical professionals, professional associations, and educators to enhance collaboration and drive innovation
Shape the future landscape of clinical practice and research through robust education on guidelines-based care to improve patient outcomes
Invest in early career investigators to inspire careers in clinical research
Provide operational oversight, ensuring effective management of budgeting, resource allocation, and performance management

Skills

Medical Education

Program Management

Strategic Planning

Leadership

Stakeholder Engagement

Global Medical Strategy

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free